Cargando…
Modification of Hemodialysis Membranes for Efficient Circulating Tumor Cell Capture for Cancer Therapy
Background: It is well known that more than 90% of cancer deaths are due to metastases. However, the entire tumorigenesis process is not fully understood, and it is evident that cells spreading from the primary tumor play a key role in initiating the metastatic process. Tumor proliferation and invas...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8398911/ https://www.ncbi.nlm.nih.gov/pubmed/34443432 http://dx.doi.org/10.3390/molecules26164845 |
_version_ | 1783744951441424384 |
---|---|
author | Jarvas, Gabor Szerenyi, Dora Tovari, Jozsef Takacs, Laszlo Guttman, Andras |
author_facet | Jarvas, Gabor Szerenyi, Dora Tovari, Jozsef Takacs, Laszlo Guttman, Andras |
author_sort | Jarvas, Gabor |
collection | PubMed |
description | Background: It is well known that more than 90% of cancer deaths are due to metastases. However, the entire tumorigenesis process is not fully understood, and it is evident that cells spreading from the primary tumor play a key role in initiating the metastatic process. Tumor proliferation and invasion also elevate the concentration of regular and irregular metabolites in the serum, which may alter the normal function of the entire human homeostasis and possibly causes cancer metabolism syndrome, also referred to as cachexia. Methods: We report on the modification of commercially available hemodialysis membranes to selectively capture circulating tumor cells from the blood stream by means of immobilized human anti-EpCAM antibodies on the inner surface of the fibers. All critical steps are described that required in situ addition of the immuno-affinity feature to hemodialyzer cartridges in order to capture EpCAM positive circulating tumor cells, which represents ~80% of cancer cell types. Results: The cell capture efficiency of the suggested technology was demonstrated by spiking HCT116 cancer cells both into buffer solution and whole blood and run through on the modified cartridge. Flow cytometry was used to quantitatively evaluate the cell clearance performance of the approach. Conclusions: The suggested modification has no significant effect on the porous structure of the hemodialysis membranes; it keeps its cytokine removal capability, addressing cachexia simultaneously with CTC removal. |
format | Online Article Text |
id | pubmed-8398911 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-83989112021-08-29 Modification of Hemodialysis Membranes for Efficient Circulating Tumor Cell Capture for Cancer Therapy Jarvas, Gabor Szerenyi, Dora Tovari, Jozsef Takacs, Laszlo Guttman, Andras Molecules Article Background: It is well known that more than 90% of cancer deaths are due to metastases. However, the entire tumorigenesis process is not fully understood, and it is evident that cells spreading from the primary tumor play a key role in initiating the metastatic process. Tumor proliferation and invasion also elevate the concentration of regular and irregular metabolites in the serum, which may alter the normal function of the entire human homeostasis and possibly causes cancer metabolism syndrome, also referred to as cachexia. Methods: We report on the modification of commercially available hemodialysis membranes to selectively capture circulating tumor cells from the blood stream by means of immobilized human anti-EpCAM antibodies on the inner surface of the fibers. All critical steps are described that required in situ addition of the immuno-affinity feature to hemodialyzer cartridges in order to capture EpCAM positive circulating tumor cells, which represents ~80% of cancer cell types. Results: The cell capture efficiency of the suggested technology was demonstrated by spiking HCT116 cancer cells both into buffer solution and whole blood and run through on the modified cartridge. Flow cytometry was used to quantitatively evaluate the cell clearance performance of the approach. Conclusions: The suggested modification has no significant effect on the porous structure of the hemodialysis membranes; it keeps its cytokine removal capability, addressing cachexia simultaneously with CTC removal. MDPI 2021-08-10 /pmc/articles/PMC8398911/ /pubmed/34443432 http://dx.doi.org/10.3390/molecules26164845 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Jarvas, Gabor Szerenyi, Dora Tovari, Jozsef Takacs, Laszlo Guttman, Andras Modification of Hemodialysis Membranes for Efficient Circulating Tumor Cell Capture for Cancer Therapy |
title | Modification of Hemodialysis Membranes for Efficient Circulating Tumor Cell Capture for Cancer Therapy |
title_full | Modification of Hemodialysis Membranes for Efficient Circulating Tumor Cell Capture for Cancer Therapy |
title_fullStr | Modification of Hemodialysis Membranes for Efficient Circulating Tumor Cell Capture for Cancer Therapy |
title_full_unstemmed | Modification of Hemodialysis Membranes for Efficient Circulating Tumor Cell Capture for Cancer Therapy |
title_short | Modification of Hemodialysis Membranes for Efficient Circulating Tumor Cell Capture for Cancer Therapy |
title_sort | modification of hemodialysis membranes for efficient circulating tumor cell capture for cancer therapy |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8398911/ https://www.ncbi.nlm.nih.gov/pubmed/34443432 http://dx.doi.org/10.3390/molecules26164845 |
work_keys_str_mv | AT jarvasgabor modificationofhemodialysismembranesforefficientcirculatingtumorcellcaptureforcancertherapy AT szerenyidora modificationofhemodialysismembranesforefficientcirculatingtumorcellcaptureforcancertherapy AT tovarijozsef modificationofhemodialysismembranesforefficientcirculatingtumorcellcaptureforcancertherapy AT takacslaszlo modificationofhemodialysismembranesforefficientcirculatingtumorcellcaptureforcancertherapy AT guttmanandras modificationofhemodialysismembranesforefficientcirculatingtumorcellcaptureforcancertherapy |